相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study
Xavier Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Treatment of Primary Sjogren Syndrome With Rituximab A Randomized Trial
Valerie Devauchelle-Pensec et al.
ANNALS OF INTERNAL MEDICINE (2014)
EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial
R. V. Moerman et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Abatacept treatment reduces disease activity in early primary Sjogren's syndrome (open-label proof of concept ASAP study)
P. M. Meiners et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjogren Syndrome The JOQUER Randomized Clinical Trial
Jacques-Eric Gottenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)
Manuel Ramos-Casals et al.
RHEUMATOLOGY (2014)
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
Jacques-Eric Gottenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
TOLERANCE AND EFFICACY OF RITUXIMAB IN PRIMARY SJOGREN SYNDROME (TEARS): RESULTS OF A RANDOMIZED CONTROLLED TRIAL
V. Devauchelle-Pensec et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjogren's Syndrome. Data at Enrollment in the Prospective ASSESS Cohort
Jacques-Eric Gottenberg et al.
PLOS ONE (2013)
European League Against Rheumatism Sjogren's Syndrome Disease Activity Index and European League Against Rheumatism Sjogren's Syndrome Patient-Reported Index: A Complete Picture of Primary Sjogren's Syndrome Patients
R. Seror et al.
ARTHRITIS CARE & RESEARCH (2013)
Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjogren's syndrome treated with rituximab
P. M. Meiners et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
Ronald F. van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
Raphaele Seror et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Effectiveness of Rituximab Treatment in Primary Sjogren's Syndrome A Randomized, Double-Blind, Placebo-Controlled Trial
J. M. Meijer et al.
ARTHRITIS AND RHEUMATISM (2010)
Accurate Detection of Changes in Disease Activity in Primary Sjogren's Syndrome by the European League Against Rheumatism Sjogren's Syndrome Disease Activity Index
Raphaele Seror et al.
ARTHRITIS CARE & RESEARCH (2010)
Novel Evidence-Based Systemic Lupus Erythematosus Responder Index
Richard A. Furie et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Patient acceptable symptomatic state (PASS)
Thao Pham et al.
JOINT BONE SPINE (2009)
Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states
D Aletaha et al.
ARTHRITIS AND RHEUMATISM (2005)
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state
F Tubach et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Inefficacy of infliximab in primary Sjogren's syndrome -: Results of the randomized, controlled trial of Remicade in primary Sjogren's syndrome (TRIPSS)
X Mariette et al.
ARTHRITIS AND RHEUMATISM (2004)
Etanercept in Sjogren's syndrome - A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial
V Sankar et al.
ARTHRITIS AND RHEUMATISM (2004)
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
C Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
分享论文
